Notification That Annual Report Will Be Submitted Late (nt 10-k)
January 29 2016 - 5:23PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
12B-25
SEC
File Number: 000-28761
CUSIP
Number: 14160X 203
NOTIFICATION
OF LATE FILING
(Check
One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form
N-SAR
For
Period Ended: October 31, 2015
[ ] |
Transition
Report on Form 10-K |
[ ] |
Transition
Report on Form 10-Q |
[ ] |
Transition
Report on Form 20-F |
[ ] |
Transition
Report on Form N-SAR |
[ ] |
Transition
Report on Form 11-K |
|
|
|
For the
Transition Period Ended: |
|
Read
attached instruction sheet before preparing form. Please print or type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
PART
I
REGISTRANT
INFORMATION
Full
name of Registrant |
CardioGenics Holdings Inc. |
Former
name if applicable |
|
Address
of principal executive office (Street and Number) |
6295 Northam Drive, Unit 8 |
City,
state and zip code |
Mississauga, Ontario L4V 1WB |
PART
II
RULE
12b-25 (b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate.)
[X] |
(a) |
The
reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
|
[X] |
(b) |
The
subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will
be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition
report on Form 10-Q or portion thereof will be filed on or before the 5th calendar day following the prescribed due date;
and |
|
|
|
[ ] |
(c) |
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III
NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could
not be filed within the prescribed time period. (Attach extra sheets if needed).
Records
and documentation necessary for completion of the narrative and financial statements for the report were not available in time
to complete the Form 10-K of the Registrant for the period ended October 31, 2015. The Registrant will file such report on or
before February 15, 2016.
PART
IV
OTHER
INFORMATION
(1) Name
and telephone number of person to contact in regard to this notification
|
Yahia
Gawad |
|
(905) |
|
673-8501 |
|
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
(2) Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If the answer is no, identify report(s).
[X] Yes [ ] No
(3) Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will
be reflected by the earnings statements to be included in the subject report or portion thereof?
[ ]
Yes [X] No
If
so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
CardioGenics
Holdings Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date
January 29, 2016 |
By: |
/s/
Yahia Gawad |
|
Name: |
Yahia
Gawad |
|
Title: |
Chief
Executive Officer |
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
From Jul 2024 to Aug 2024
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
From Aug 2023 to Aug 2024